Thirman Michael J
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Cancer Cell. 2017 Jun 12;31(6):729-731. doi: 10.1016/j.ccell.2017.05.014.
Conflicting data exist on the requirement for wild-type MLL1 in MLL-rearranged leukemia. In this issue of Cancer Cell, Chen et al. describe complementary approaches demonstrating that MLL1 is dispensable for MLL-fusion-mediated leukemogenesis. They also observe an unexpected role for MLL2 in MLL-rearranged leukemia cells and identify potential therapeutic targets.
关于野生型MLL1在MLL重排白血病中的需求存在相互矛盾的数据。在本期《癌细胞》杂志中,陈等人描述了互补方法,证明MLL1对于MLL融合介导的白血病发生是可有可无的。他们还观察到MLL2在MLL重排白血病细胞中的意外作用,并确定了潜在的治疗靶点。